BlackRock Investment Management, LLC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$8,304,000
-9.4%
667,499
-0.3%
0.01%
-9.1%
Q3 2016$9,168,000
+86.6%
669,672
+0.7%
0.01%
+83.3%
Q2 2016$4,913,000
+30.7%
664,847
+13.0%
0.01%
+20.0%
Q1 2016$3,759,000
+6.7%
588,332
+4.4%
0.01%0.0%
Q4 2015$3,522,000
+7.3%
563,474
+0.3%
0.01%
+25.0%
Q3 2015$3,281,000
-30.1%
561,742
-1.1%
0.00%
-33.3%
Q2 2015$4,697,000
+25.0%
567,997
+24.5%
0.01%
+20.0%
Q1 2015$3,759,000
+21.9%
456,151
+1.6%
0.01%
+25.0%
Q4 2014$3,084,000
+25.9%
448,920
-1.0%
0.00%
+33.3%
Q3 2014$2,449,000
-14.8%
453,585
+0.5%
0.00%
-25.0%
Q2 2014$2,875,000
+473.9%
451,299
+626.4%
0.00%
+300.0%
Q1 2014$501,000
+16.5%
62,127
-1.4%
0.00%0.0%
Q4 2013$430,000
-86.2%
63,037
-62.7%
0.00%
-80.0%
Q3 2013$3,106,000
+132.3%
168,791
+120.8%
0.01%
+150.0%
Q2 2013$1,337,00076,4340.00%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$94,961,00026.95%
Consonance Capital Management LP 8,845,742$65,370,0009.25%
Opaleye Management Inc. 1,250,000$9,238,0006.17%
Tamarack Advisers, LP 2,100,000$15,519,0005.95%
IRONWOOD INVESTMENT MANAGEMENT LLC 293,352$2,168,0001.62%
Camber Capital Management LP 4,000,000$29,560,0001.43%
Palo Alto Investors LP 2,535,117$18,735,0001.42%
Granite Point Capital Management, L.P. 430,890$3,184,0001.37%
1492 Capital Management LLC 202,500$1,496,0001.34%
HighVista Strategies LLC 869,100$6,423,0001.23%
View complete list of ARIAD PHARMACEUTICALS INC shareholders